166 related articles for article (PubMed ID: 23647681)
1. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
Yasar U; Greenblatt DJ; Guillemette C; Court MH
J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
[TBL] [Abstract][Full Text] [Related]
2. Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.
Court MH
Drug Metab Rev; 2010 Feb; 42(1):209-24. PubMed ID: 19821798
[TBL] [Abstract][Full Text] [Related]
3. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
[TBL] [Abstract][Full Text] [Related]
4. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
[TBL] [Abstract][Full Text] [Related]
5. Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells.
Bélanger AS; Tojcic J; Harvey M; Guillemette C
BMC Mol Biol; 2010 Jan; 11():9. PubMed ID: 20096102
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
[TBL] [Abstract][Full Text] [Related]
8. Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes.
Peterkin VC; Bauman JN; Goosen TC; Menning L; Man MZ; Paulauskis JD; Williams JA; Myrand SP
Br J Clin Pharmacol; 2007 Oct; 64(4):458-68. PubMed ID: 17555467
[TBL] [Abstract][Full Text] [Related]
9. Histone Modifications Regulate the Developmental Expression of Human Hepatic UDP-Glucuronosyltransferase 1A1.
Nie YL; Meng XG; Liu JY; Yan L; Wang P; Bi HZ; Kan QC; Zhang LR
Drug Metab Dispos; 2017 Dec; 45(12):1372-1378. PubMed ID: 29025858
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
[TBL] [Abstract][Full Text] [Related]
11. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
[TBL] [Abstract][Full Text] [Related]
12. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver.
Li Y; Buckley D; Wang S; Klaassen CD; Zhong XB
Drug Metab Dispos; 2009 Sep; 37(9):1978-86. PubMed ID: 19541828
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation is a crucial factor in the repression of UGT1A1 expression in the human kidney.
Oda S; Fukami T; Yokoi T; Nakajima M
Drug Metab Dispos; 2013 Oct; 41(10):1738-43. PubMed ID: 23401472
[TBL] [Abstract][Full Text] [Related]
15. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
Innocenti F; Grimsley C; Das S; Ramírez J; Cheng C; Kuttab-Boulos H; Ratain MJ; Di Rienzo A
Pharmacogenetics; 2002 Dec; 12(9):725-33. PubMed ID: 12464801
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
Watanabe Y; Nakajima M; Yokoi T
Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
[TBL] [Abstract][Full Text] [Related]
17. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
[TBL] [Abstract][Full Text] [Related]
18. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
[TBL] [Abstract][Full Text] [Related]
19. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome.
Peters WH; te Morsche RH; Roelofs HM
J Hepatol; 2003 Jan; 38(1):3-8. PubMed ID: 12480553
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant.
Fang JL; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):102-9. PubMed ID: 14744740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
